CHAPEL HILL, N.C., Nov 08, 2011 (BUSINESS WIRE) --
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to
transforming medicine that transforms lives, announced today that John
R. Plachetka, Pharm.D., the Company's Chairman, President and Chief
Executive Officer will participate in the Brean Murray Carret & Co. 2011
Life Sciences Summit, on Monday, November 14, 2011 at the Grand Hyatt
Hotel in New York City.
POZEN Inc. is a progressive pharmaceutical company that is transforming
how the healthcare industry addresses unmet medical needs. By utilizing
a unique in-source model and focusing on integrated therapies, POZEN has
successfully developed and obtained FDA approval of two self-invented
products in two years - something almost no other small pharmaceutical
company has done. Funded by these two milestone/royalty streams, POZEN
is now creating a portfolio of cost-effective, evidence based integrated
aspirin therapies designed to enable the full power of aspirin by
reducing its GI damage.
The Company's common stock is traded on The NASDAQ Global Market under
the symbol "POZN". For more detailed company information, including
copies of this and other press releases, please visit www.pozen.com.
SOURCE: POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
Stephanie Bonestell, 919-913-1030
Manager, Investor Relations & Public Relations